Skip to content
Open access · CC-BY via OpenAlex

Reprogramming Skin Aging: A Regenerative and Epigenetic Perspective on Cutaneous Longevity

Diala Haykal, Michael Gold, Edward Lain, Jeremy Green, Patricia K. Farris

Journal of Cosmetic Dermatology · 2026

Abstract

Aesthetic dermatology is undergoing a transformative shift, one that mirrors the broader societal focus on longevity and proactive health optimization. Traditionally, the goals of aesthetic medicine were tied to visible rejuvenation, smoothing wrinkles, restoring volume, and refining contours. Today, patients increasingly seek interventions that not only enhance appearance, but also preserve the vitality, structure, and biological performance of their skin over time. This shift reflects the evolving science of longevity, which distinguishes between lifespan, the number of years a person lives, and healthspan(definition), the number of years lived in good health, free from disease and functional decline. In dermatology, an analogous concept is emerging, skin healthspan, or skinspan, the duration over which the skin maintains optimal barrier function, immune defense, regenerative capacity, and aesthetic quality [1]. Cutaneous aging, like systemic aging, is now understood as a modifiable process, shaped by intrinsic genetic programs and extrinsic stressors such as UV exposure, pollution, and inflammation. Advances in epigenetics, cellular senescence(definition) research, and regenerative technologies offer an opportunity to shift the focus from late-stage correction to early, proactive biological support [2]. This commentary explores mechanistic pathways underlying skin longevity, including telomeric preservation, epigenetic clocks, senescence reversal via partial reprogramming(definition), and the modulation of mitochondrial function through biomimetic peptides and non-ablative energy-based technologies. Cutaneous aging, once thought to be an inevitable accumulation of damage, is now understood as a modifiable process governed by intrinsic molecular pathways and extrinsic environmental influences. Telomere(definition) shortening, mitochondrial decline, and epigenetic drift represent key intrinsic changes driving cellular senescence. While these processes have been predominantly studied in fibroblasts due to their experimental accessibility, they are believed to affect all skin cell populations, including keratinocytes and melanocytes. These intrinsic alterations collectively impair extracellular matrix homeostasis and epidermal renewal, contributing to global skin aging [3]. Emerging evidence from in vivo and in vitro studies indicates that partial cellular reprogramming, particularly through transient expression of Yamanaka factors or through defined mRNA-based cocktails composed of short-lived synthetic mRNAs encoding selected epigenetic modifiers, transcriptional regulators, and rejuvenation-associated factors [4]. While full reprogramming induces pluripotency, partial approaches reset epigenetic marks, improve mitochondrial function, and restore youthful transcriptomic signatures. In the context of skin, fibroblasts and keratinocytes exhibit remarkable responsiveness to reprogramming stimuli, suggesting that the skin may serve as an ideal organ for testing rejuvenation paradigms [5]. Recent studies have shown that localized, controlled reprogramming can reduce senescence markers, enhance extracellular matrix remodeling, and potentially extend cellular healthspan [6, 7]. These insights pave the way for non-invasive or minimally invasive interventions that mimic or trigger endogenous reprogramming pathways, whether via energy-based devices (EBDs), topically delivered RNAs, or nanocarrier systems targeting epigenetic regulators [8]. Recent advances in biogerontology have identified twelve hallmarks of aging(definition), including genomic instability, loss of proteostasis(definition), cellular senescence, chronic inflammation, altered mechanical properties, disabled macroautophagy, among others, and epigenetic alterations among others [9]. These hallmarks are not only relevant to systemic aging but also manifest distinctly in the skin, where they drive visible and functional decline. Importantly, each hallmark is associated with measurable biomarkers, such as advanced glycation end products (AGEs), matrix metalloproteinase (MMP) activity, and senescence-associated β-galactosidase expression [10]. In dermatology, tracking these biomarkers opens the door to objective assessment of skin aging and responsiveness to intervention [11]. Epigenetic clocks based on DNA methylation patterns have emerged as precise biomarkers for biological age. Recent efforts have tailored these clocks to skin-specific contexts, revealing their utility in capturing both intrinsic aging and cumulative environmental stress [12-14]. The development of such metrics enables clinicians to move beyond chronological age and assess the regenerative potential of skin in a more biologically meaningful way. This shift repositions the goal of dermatological intervention from cosmetic improvement to upstream modulation of aging pathways, laying the groundwork for integrative longevity care. This scientific framing shifts the goal in aesthetic medicine: no longer to camouflage signs of aging but to act upstream, targeting the cellular and molecular dysfunctions that underlie cutaneous deterioration. This paradigm demands a new generation of tools, technological, molecular, and diagnostic, that go beyond symptom management and support true regenerative care. Non-ablative EBDs, such as fractional lasers, microneedling radiofrequency, and photobiomodulation systems, have emerged as pivotal tools in regenerative dermatology. Unlike ablative devices, which thermally ablate the epidermis and dermis and require extended recovery, non-ablative modalities act on deeper dermal structures while for the most part preserving the skin barrier. These devices trigger controlled dermal microinjury, which activates fibroblasts, stimulates angiogenesis, and enhances extracellular matrix remodeling [15]. Recent findings suggest that the biological effects of these technologies extend to epigenetic modulation [16]. As demonstrated in Haykal's study on laser-induced epigenetic modulation, non-ablative fractional lasers may

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1111/jocd.70788
Canonical
link ↗
Fetched
2026-06-05 MST

Cite this

APA
Haykal, D., Gold, M., Lain, E., Green, J., &amp; Farris, P.K. (2026). Reprogramming Skin Aging: A Regenerative and Epigenetic Perspective on Cutaneous Longevity. <em>Journal of Cosmetic Dermatology</em>. https://doi.org/10.1111/jocd.70788
Vancouver
Haykal D, Gold M, Lain E, Green J, Farris PK. Reprogramming Skin Aging: A Regenerative and Epigenetic Perspective on Cutaneous Longevity. Journal of Cosmetic Dermatology. 2026. doi:10.1111/jocd.70788.
BibTeX
@article{diala2026Reprog, title = {Reprogramming Skin Aging: A Regenerative and Epigenetic Perspective on Cutaneous Longevity}, author = {Diala Haykal and Michael Gold and Edward Lain and Jeremy Green and Patricia K. Farris}, journal = {Journal of Cosmetic Dermatology}, year = {2026}, doi = {10.1111/jocd.70788}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings